8158.Hk
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company maintains a debt-to-equity ratio of 0.96, indicating a moderate level of leverage, while its current ratio of 1.14 suggests limited short-term liquidity. With total cash and equivalents of HKD 8,169,000 and long-term debt of HKD 51,306,000, the company is net cash negative, which could pose a liquidity risk if short-term obligations exceed available cash.
Profitability metrics show a return on equity of 51.47% and a return on assets of 16.38%, both of which are strong indicators of efficient capital use and asset management. These figures suggest the company is outperforming typical industry benchmarks for profitability, although specific cohort medians are not provided in the data.
The company's revenue is not segmented by product or geographic region in the available data, making it difficult to assess the concentration of risk or growth potential in specific areas. However, the lack of detailed segment reporting may indicate a relatively concentrated business model or limited diversification.
Looking ahead, the company's growth trajectory is not explicitly outlined in the data, but its strong profitability and moderate leverage suggest a stable financial position. The absence of detailed outlook data means that future revenue growth or contraction cannot be quantified at this time.
The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash negative position is a key flag, suggesting potential pressure on liquidity if cash flow from operations does not meet expectations. No dilution sources are identified in the data, and the dilution potential is assessed as low, indicating that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders.
No recent events, such as filings or transcripts, are provided in the data to inform the company's current strategic direction or operational performance.
- The company demonstrates strong profitability with a return on equity of 51.47% and a return on assets of 16.38%.
- The company is net cash negative, which could pose a liquidity risk if cash flow from operations is insufficient to meet obligations.
- The debt-to-equity ratio of 0.96 indicates a moderate level of leverage, suggesting a balanced capital structure.
- The company's financial position is stable, with a current ratio of 1.14, but the lack of detailed segment or geographic data limits the ability to assess diversification risk.
- The risk assessment highlights a medium liquidity risk and a low dilution risk, indicating a relatively stable capital structure.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Assetsnet_income / total_assets
- 8158.HK Market data — financials · 2026-05-27